Biosev talks bonds, capital increase
Brazilian agri firm leans toward a follow-on equity offering but does not rule out a DCM deal, sources say...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.